[Lung cancer screening].

[Lung cancer screening].
Radiologe. 2018 Dec 12;:
Authors: Prosch H, Ebner L
Abstract
CLINICAL/METHODICAL ISSUE: The National Lung Screening Trial (NLST) in 2011 was able to prove for the first time that screening with a low-dose CT can reduce lung carcinoma mortality by 20%. Despite the positive outcome of the NLST, there is-unlike in the USA-currently no systematic lung cancer screening in Europe. This is partly because several significantly smaller screening studies in Europe failed to show any improvement in lung cancer mortality.
STANDARD RADIOLOGICAL METHODS: On the other hand, Europe's healthcare systems differ substantially from those in the United States, so that a direct transfer of US experience to Europe is not possible. For this reason, guidelines for lung cancer screening must be developed in the individual European countries to ensure that lung cancer mortality can be reduced by means of a quality-assured and cost-effective lung cancer screening.
PRACTICAL RECOMMENDATIONS: The experience and the expected results of the European screening studies can provide valuable help for these purposes.
PMID: 30542924 [PubMed - as supplied by publisher]

Source: Der Radiologe - December 12, 2018 Category: Radiology Authors: Prosch H, Ebner L Tags: Radiologe Source Type: research